Dae Han New Pharm Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dae Han New Pharm Co., Ltd. with three other
companies in this sector in South Korea:
Theragen Etex Co Limited
sales of 101.28 billion Korean Won [US$89.74 million]
Celltrion Pharm Incorporated
(104.81 billion Korean Won [US$92.86 million]
of which 100%
was Pharmaceutical), and
Hyundai Pharmaceutical Company Limited
(120.02 billion Korean Won [US$106.34 million]
of which 86%
Dae Han New Pharm Co., Ltd. reported sales of 109.40 billion Korean Won (US$96.93 million)
December of 2016.
increase of 21.2%
versus 2015, when the company's sales were 90.23 billion Korean Won.
Sales at Dae Han New Pharm Co., Ltd. have increased during each of the previous five years
(and since 2011, sales have increased a total of 146%).